Aurora Cannabis to Discuss Fiscal Year 2025 Results in Upcoming Investor Call

Aurora Cannabis ( (TSE:ACB) ) has issued an announcement.

Aurora Cannabis announced it will host a conference call on June 18, 2025, to discuss its fourth quarter and fiscal year 2025 financial results. This announcement highlights the company’s commitment to transparency and engagement with investors, which could impact its market positioning and stakeholder relations positively.

The most recent analyst rating on (TSE:ACB) stock is a Hold with a C$11.00 price target. To see the full list of analyst forecasts on Aurora Cannabis stock, see the TSE:ACB Stock Forecast page.

Spark’s Take on TSE:ACB Stock

According to Spark, TipRanks’ AI Analyst, TSE:ACB is a Neutral.

Aurora Cannabis scores a 50, reflecting a balance of significant financial difficulties and promising operational improvements. The positive earnings call and strategic corporate moves suggest potential growth, but the persistent financial challenges and high valuation limit the overall score. Continued focus on profitability and operational efficiency will be crucial.

To see Spark’s full report on TSE:ACB stock, click here.

More about Aurora Cannabis

Aurora Cannabis Inc. is a leading global medical cannabis company based in Edmonton, Alberta, Canada. It serves both medical and consumer markets across Canada, Europe, Australia, and New Zealand. The company offers a diverse range of cannabis products through its adult-use and medical cannabis brands, including Drift, San Rafael ’71, Daily Special, Tasty’s, Being, Greybeard, MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, IndiMed, and CraftPlant. Aurora also holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America.

Average Trading Volume: 449,518

Technical Sentiment Signal: Sell

Current Market Cap: C$391.9M

See more data about ACB stock on TipRanks’ Stock Analysis page.